IN2012DN02668A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02668A
IN2012DN02668A IN2668DEN2012A IN2012DN02668A IN 2012DN02668 A IN2012DN02668 A IN 2012DN02668A IN 2668DEN2012 A IN2668DEN2012 A IN 2668DEN2012A IN 2012DN02668 A IN2012DN02668 A IN 2012DN02668A
Authority
IN
India
Prior art keywords
porous scaffold
plug
cells
cell
host body
Prior art date
Application number
Other languages
English (en)
Inventor
Craig Hasilo
Justin Leushner
Daniel Nicholas Haworth
Simon Shohet
Philip Michael Toleikis
Delfina Maria Mazzuca Siroen
Original Assignee
Sernova Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sernova Corp filed Critical Sernova Corp
Publication of IN2012DN02668A publication Critical patent/IN2012DN02668A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/022—Artificial gland structures using bioreactors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A61M2039/0282—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body with implanted tubes connected to the port
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
IN2668DEN2012 2009-08-28 2010-08-27 IN2012DN02668A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23801109P 2009-08-28 2009-08-28
PCT/US2010/047028 WO2011025977A2 (en) 2009-08-28 2010-08-27 Methods and devices for cellular transplantation

Publications (1)

Publication Number Publication Date
IN2012DN02668A true IN2012DN02668A (ru) 2015-09-04

Family

ID=43466432

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2668DEN2012 IN2012DN02668A (ru) 2009-08-28 2010-08-27

Country Status (26)

Country Link
US (5) US9011899B2 (ru)
EP (2) EP2470228B1 (ru)
JP (7) JP5756108B2 (ru)
KR (5) KR102194187B1 (ru)
CN (1) CN102596273B (ru)
AU (1) AU2010286531B2 (ru)
BR (1) BR112012004385B1 (ru)
CA (1) CA2772375C (ru)
CY (2) CY1119719T1 (ru)
DK (2) DK3290061T3 (ru)
EA (3) EA025142B1 (ru)
ES (2) ES2806645T3 (ru)
HK (1) HK1247860A1 (ru)
HR (2) HRP20171926T1 (ru)
HU (2) HUE051328T2 (ru)
IL (1) IL218360A (ru)
IN (1) IN2012DN02668A (ru)
LT (2) LT3290061T (ru)
MX (2) MX2012002440A (ru)
NO (1) NO2470228T3 (ru)
NZ (2) NZ615383A (ru)
PL (2) PL3290061T3 (ru)
PT (2) PT3290061T (ru)
SG (3) SG10202001012VA (ru)
SI (2) SI3290061T1 (ru)
WO (1) WO2011025977A2 (ru)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105349517B (zh) 2008-11-14 2021-05-04 维赛特公司 源于人多能干细胞的胰腺细胞的包封
HUE051328T2 (hu) * 2009-08-28 2021-03-01 Sernova Corp Sejttranszplantációs módszerek és eszközök
EP2404672A1 (en) * 2010-07-06 2012-01-11 Universiteit Twente High troughput multiwell system for culturing 3D tissue constructs in-vitro or in-vivo, method for producing said multiwell system and methods for preparing 3D tissue constructs from cells using said multiwell system
MX2010013135A (es) * 2010-11-30 2012-05-31 Val De Bio S De R L De C V Procedimiento y dispositivo mejorados para favorecer el trasplante de material biológico.
US9526880B2 (en) * 2013-03-07 2016-12-27 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device assembly
WO2014197798A2 (en) * 2013-06-07 2014-12-11 The Regents Of The University Of California Transplantation device and method of use
CN104195105B (zh) * 2014-08-19 2017-10-27 杭州安体科技有限公司 一种提高人精子活力的体外培养体系试剂盒及其使用方法
US10434122B2 (en) * 2014-09-24 2019-10-08 The Governors Of The University Of Alberta Cellular transplant site
EP3273949A4 (en) 2015-03-23 2018-12-12 The Regents of The University of California Thin film cell encapsulation devices
CA2994934A1 (en) * 2015-08-06 2017-02-09 Lockheed Martin Corporation Implantable graphene membranes with low cytotoxicity
WO2017087676A1 (en) * 2015-11-19 2017-05-26 Tepha, Inc. Methods to produce perforated collagen coated surgical meshes
WO2017180141A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Selective interfacial mitigation of graphene defects
US10967102B2 (en) 2016-09-28 2021-04-06 Boston Scientific Limited Cell encapsulation membranes, devices and methods
WO2018071967A1 (en) * 2016-10-20 2018-04-26 Australian Foundation for Diabetes Research Cell associated scaffolds for delivery of agents
CN115429222A (zh) * 2016-11-03 2022-12-06 代表亚利桑那大学的亚利桑那董事会 用于改进血糖调节的方法、系统和可植入装置
AU2017396754B2 (en) 2016-11-03 2021-08-05 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods and systems for real-time assessment of cells in encapsulation devices pre-and post-transplantation
CA3042866A1 (en) 2016-11-03 2018-05-11 Klearchos K. Papas Encapsulation device systems with oxygen sensors with or without exogenous oxygen delivery
US11052230B2 (en) * 2016-11-08 2021-07-06 W. L. Gore & Associates, Inc. Implantable encapsulation devices
CN110167455B (zh) 2016-11-10 2022-10-11 韦尔赛特公司 含有pdx1胰腺内胚层细胞的细胞递送装置及其方法
JP6557717B2 (ja) * 2016-12-23 2019-08-07 インスコビー・インコーポレイテッドＩｎｓｃｏｂｅｅ，Ｉｎｃ． 生体植立用インプラント及びその製造方法
KR101952762B1 (ko) * 2017-05-08 2019-02-27 강원대학교산학협력단 알긴산과 콜라겐의 조합으로 생성된 줄기세포를 캡슐화하는 미세캡슐 조성물 및 그 제조방법
RU2663470C2 (ru) * 2017-05-11 2018-08-06 Федеральное государственное бюджетное образовательное учреждение высшего образования "Казанский государственный медицинский университет" Способ стимулирования ангиогенеза с использованием генетически модифицированных клеток крови пуповины
EP3409239A1 (en) 2017-05-29 2018-12-05 University College Dublin, National University of Ireland, Dublin An implantable active agent encapsulating device
CN107376033B (zh) * 2017-07-26 2019-03-26 湖南赛诺生物科技股份有限公司 一种细胞移植增效保护装置及其制备方法
JP7101377B2 (ja) 2017-09-15 2022-07-15 株式会社日立製作所 細胞培養基材、細胞培養容器、及び細胞培養方法
US11565094B2 (en) 2017-10-17 2023-01-31 The Methodist Hospital System Delivery devices
GB201717885D0 (en) * 2017-10-31 2017-12-13 Hothouse Medical Ltd Prothesis and method of manufacture
US11523995B2 (en) 2017-11-30 2022-12-13 Duke University Compositions and methods for ablating niche cells in testis and other epithelial cells and methods relating thereto
EP3758722A1 (en) 2018-03-01 2021-01-06 Seraxis, Inc. Macro-encapsulated therapeutic cells, devices, and methods of using the same
RU2682160C2 (ru) * 2018-05-28 2019-03-15 Игорь Валерьевич Саматошенков Способ регенерации нервных волокон кровеносных сосудов
US20210290821A1 (en) * 2018-07-27 2021-09-23 Washington University Cell-embedded vascular graft for transplantation
WO2020028885A1 (en) * 2018-08-02 2020-02-06 Georgetown University Methods and compositions for cell transplantation
US11963862B2 (en) 2018-08-22 2024-04-23 Boston Scientific Scimed, Inc. Cell encapsulation device including a porous tube
SG11202102910VA (en) * 2018-09-24 2021-04-29 Procyon Tech Llc Methods and systems for implantable medical devices and vascularization membranes
WO2020138028A1 (ja) * 2018-12-25 2020-07-02 富士フイルム株式会社 細胞移植キット、袋状構造物の製造方法、および糖尿病治療剤
EP3962505A1 (en) 2019-05-01 2022-03-09 Sernova Corporation Methods of treating diabetes using devices for cellular transplantation
KR20220070474A (ko) 2019-09-27 2022-05-31 이슬라 테크놀로지스, 인크. 생체인공 췌장
MX2022008636A (es) * 2020-01-13 2022-08-08 Incube Labs Llc Articulos de suministro de celulas y metodos de administracion.
CN115443142A (zh) * 2020-02-10 2022-12-06 优美佳生物技术有限公司 胰岛移植装置、套件和方法

Family Cites Families (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3866609A (en) 1972-04-05 1975-02-18 Charles Howard Sparks Apparatus for growing graft tubes in place
CA1340581C (en) 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US5786216A (en) * 1987-11-17 1998-07-28 Cytotherapeutics, Inc. Inner-supported, biocompatible cell capsules
WO1991000119A1 (en) * 1989-06-30 1991-01-10 Baxter International Inc. Implantable device
US5100392A (en) 1989-12-08 1992-03-31 Biosynthesis, Inc. Implantable device for administration of drugs or other liquid solutions
US5733336A (en) * 1990-10-31 1998-03-31 Baxter International, Inc. Ported tissue implant systems and methods of using same
CA2121040A1 (en) 1991-10-30 1993-05-13 James E. Stein Prevascularized polymeric implants for organ transplantation
US6352707B1 (en) 1992-02-24 2002-03-05 Anton-Lewis Usala Transplant encapsulation in a hydrogel matrix to obscure immune recognition
US6231881B1 (en) 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
US5425764A (en) 1992-07-30 1995-06-20 The University Of Toledo Bioartificial pancreas
US5262055A (en) 1992-10-19 1993-11-16 The University Of Utah Implantable and refillable biohybrid artificial pancreas
US6689608B1 (en) 1993-02-01 2004-02-10 Massachusetts Institute Of Technology Porous biodegradable polymeric materials for cell transplantation
EP0708670A4 (en) * 1993-06-23 1998-07-01 Cytotherapeutics Inc METHOD AND APPARATUS FOR HERMETICALLY CLOSING IMPLANTABLE MEMBRANE ENCAPSULATING DEVICES
EP1174156A2 (en) * 1994-01-11 2002-01-23 Baxter International Inc. Ported tissue implant systems and methods of using same
US5686091A (en) * 1994-03-28 1997-11-11 The Johns Hopkins University School Of Medicine Biodegradable foams for cell transplantation
US5620883A (en) 1994-04-01 1997-04-15 The Johns Hopkins University Living cells microencapsulated in a polymeric membrane having two layers
EP0755258B1 (en) 1994-04-13 2002-01-23 Research Corporation Technologies, Inc Methods of treating disease using sertoli cells and allografts or xenografts
US5958404A (en) 1994-04-13 1999-09-28 Research Corporation Technologies, Inc. Treatment methods for disease using co-localized cells and Sertoli cells obtained from a cell line
US5849285A (en) 1994-04-13 1998-12-15 Research Corporation Technologies, Inc. Autoimmune disease treatment with sertoli cells and in vitro co-culture of mammal cells with sertoli cells
US6703017B1 (en) 1994-04-28 2004-03-09 Ixion Biotechnology, Inc. Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
US7018419B2 (en) 1994-05-20 2006-03-28 Spielberg Theodore E Microporous encapsulated endocrine cell disks, biconcave disks and multidimpled chambers for hormonal replacement
US20060263406A1 (en) 1994-07-01 2006-11-23 Lyles Mark B Implantable System for Cell Growth Control
US5840576A (en) * 1994-07-20 1998-11-24 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
GB9506844D0 (en) 1995-04-03 1995-05-24 Armitage Ian M Pharmaceutical microencapsulation
EP0773753B1 (en) 1995-06-07 2003-10-08 Gore Hybrid Technologies, Inc. An implantable containment apparatus for a therapeutical device
US5741334A (en) 1995-06-07 1998-04-21 Circe Biomedical, Inc. Artificial pancreatic perfusion device
DE69637842D1 (de) 1995-10-26 2009-04-02 Paul P Latta Induktion von immunologischer Toleranz
US5964261A (en) * 1996-05-29 1999-10-12 Baxter International Inc. Implantation assembly
US6054142A (en) * 1996-08-01 2000-04-25 Cyto Therapeutics, Inc. Biocompatible devices with foam scaffolds
US5881733A (en) 1996-09-13 1999-03-16 Depuy Orthopaedic Technology, Inc. Technique for osteocartilaginous transplantation in a mammalian joint
US6303136B1 (en) 1998-04-13 2001-10-16 Neurotech S.A. Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
US7399751B2 (en) 1999-11-04 2008-07-15 Sertoli Technologies, Inc. Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
CN1204854C (zh) 1998-12-15 2005-06-08 墨西哥国家自治大学 有利于生物材料植入的装置
WO2002043800A2 (en) * 2000-11-29 2002-06-06 Durect Corporation Devices and methods for controlled delivery from a drug delivery device
WO2000064954A1 (en) 1999-04-22 2000-11-02 Vanderbilt University Polymeric encapsulation system promoting angiogenesis
US7759113B2 (en) 1999-04-30 2010-07-20 The General Hospital Corporation Fabrication of tissue lamina using microfabricated two-dimensional molds
US7371400B2 (en) 2001-01-02 2008-05-13 The General Hospital Corporation Multilayer device for tissue engineering
US20020151055A1 (en) 1999-11-02 2002-10-17 Stegemann Jan Philip Novel artificial pancreas
US6479066B1 (en) * 1999-12-16 2002-11-12 Rst Implanted Cell Technology, Llc Device having a microporous membrane lined deformable wall for implanting cell cultures
AU2001258091A1 (en) 2000-05-05 2001-11-20 Mcgill University A device for cell implantation
ES2386505T3 (es) * 2000-10-17 2012-08-22 Diatranz Otsuka Limited Preparación y xenotrasplante de islotes de cerdo
US6517888B1 (en) 2000-11-28 2003-02-11 Scimed Life Systems, Inc. Method for manufacturing a medical device having a coated portion by laser ablation
US20020155559A1 (en) * 2001-01-17 2002-10-24 Laurencin Cato T. Biocompatible, biodegradable polymer-based, lighter than or light as water scaffolds for tissue engineering and methods for preparation and use thereof
US20030068308A1 (en) 2001-10-09 2003-04-10 Jacek Rozga Intrasplenic encapsulated cell therapy
TWI222997B (en) * 2001-12-10 2004-11-01 Ind Tech Res Inst Method for tissue culture in vitro
JP2003190259A (ja) 2001-12-28 2003-07-08 Hisako Ogawara 人工臓器用チャンバー
RU2240755C2 (ru) * 2002-02-26 2004-11-27 Колганов Андрей Сергеевич Устройство для имплантации клеточной культуры
US20030181978A1 (en) 2002-03-25 2003-09-25 Brown Kelly R. Channeled biomedical foams and method for producing same
JP2006503080A (ja) 2002-10-11 2006-01-26 ノボセル インコーポレイテッド 疾患治療用のカプセルで包んだ生物材料の移植
US7044965B1 (en) 2002-12-13 2006-05-16 Spielberg Theodore E Therapeutic cellular stent
US20040156878A1 (en) * 2003-02-11 2004-08-12 Alireza Rezania Implantable medical device seeded with mammalian cells and methods of treatment
US20040197374A1 (en) * 2003-04-02 2004-10-07 Alireza Rezania Implantable pouch seeded with insulin-producing cells to treat diabetes
CA2848954A1 (en) 2003-07-03 2005-03-03 Sertoli Technologies, Llc Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
US8043614B2 (en) 2004-03-09 2011-10-25 Ahlfors Jan-Eric W Autogenic living scaffolds and living tissue matrices: methods and uses thereof
US20050180957A1 (en) 2004-01-16 2005-08-18 Scharp David W. Method of using fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells
WO2005089673A1 (en) 2004-03-24 2005-09-29 Mika Lahtinen New product
CN101022769A (zh) 2004-07-29 2007-08-22 迈阿密大学 用于细胞治疗的杂交装置
US9788978B2 (en) 2004-12-20 2017-10-17 Nicholas A. Rojo Implantable systems and stents containing cells for therapeutic uses
US20090028945A1 (en) 2005-06-04 2009-01-29 University Of Colorado Immunoisolative encapsulation system
ATE534415T1 (de) 2005-12-13 2011-12-15 Harvard College Gerüste zur zelltransplantation
WO2008008266A2 (en) 2006-07-07 2008-01-17 University Of Pittsburgh- Of The Commonwealth System Of Higher Education Biohybrid elastomeric scaffolds and methods of use thereof
JP5214161B2 (ja) * 2006-07-10 2013-06-19 オリンパス株式会社 透過光学素子及びそれを用いた光学系
CA2658951A1 (en) 2006-07-28 2008-01-31 Sertocell Biotechnology (Us) Corp. Adult sertoli cells and uses thereof
WO2008079997A2 (en) * 2006-12-22 2008-07-03 Medtronic, Inc. Implantable device, angiogenesis mechanism and methods
WO2008097498A1 (en) 2007-02-02 2008-08-14 University Of Miami Therapeutic hybrid implantable devices
US7875072B2 (en) 2007-03-26 2011-01-25 Spielberg Theodore E Cellular transplant stent
CN101778891B (zh) 2007-06-13 2013-01-16 Fmc有限公司 涂覆藻酸盐的含多糖凝胶泡沫复合物,其制备方法及其应用
US8821431B2 (en) 2007-09-07 2014-09-02 Beta O2 Technologies Ltd. Air gap for supporting cells
EP2278883A4 (en) 2008-04-25 2012-11-28 Encapsulife Inc IMMUNIZATION PATCH SYSTEM FOR CELL TRANSPLANT
US9446168B2 (en) 2010-06-07 2016-09-20 Beta-O2 Technologies Ltd. Multiple-layer immune barrier for donor cells
WO2010032242A1 (en) 2008-09-17 2010-03-25 Beta O2 Technologies Ltd. Optimization of alginate encapsulation of islets for transplantation
CN105349517B (zh) 2008-11-14 2021-05-04 维赛特公司 源于人多能干细胞的胰腺细胞的包封
US9109245B2 (en) 2009-04-22 2015-08-18 Viacyte, Inc. Cell compositions derived from dedifferentiated reprogrammed cells
EP2286822A1 (en) 2009-08-17 2011-02-23 Universiteit Twente Diabetes treatment
HUE051328T2 (hu) 2009-08-28 2021-03-01 Sernova Corp Sejttranszplantációs módszerek és eszközök
US20120252045A1 (en) 2009-09-03 2012-10-04 Andrew Pepper Method of assessing islet function
WO2011130322A1 (en) 2010-04-12 2011-10-20 University Of Miami Macroporous bioengineered scaffolds for cell transplantation
EP2422823B1 (en) 2010-07-30 2014-03-19 Institut Quimic De Sarria Bioactive implant
FR2962898B1 (fr) 2010-07-22 2012-08-17 Statice Sante Poche pour former un organe artificiel implantable
US20120083767A1 (en) 2010-10-01 2012-04-05 The Johns Hopkins University Implantable bioreactor for delivery of paracrine factors
MX2010013135A (es) 2010-11-30 2012-05-31 Val De Bio S De R L De C V Procedimiento y dispositivo mejorados para favorecer el trasplante de material biológico.
US8936650B2 (en) 2011-03-23 2015-01-20 The Regents Of The University Of California Mesh enclosed tissue constructs
US8579990B2 (en) 2011-03-30 2013-11-12 Ethicon, Inc. Tissue repair devices of rapid therapeutic absorbency
US9248013B2 (en) 2011-12-05 2016-02-02 California Institute Of Technology 3-Dimensional parylene scaffold cage
US10675138B2 (en) 2011-12-07 2020-06-09 The Trustees Of Princeton University Scaffolds for soft tissue and uses thereof
WO2013134360A1 (en) 2012-03-06 2013-09-12 The Uab Research Foundation Technologies for pancreatic islet transplantation
US9101707B2 (en) 2012-04-27 2015-08-11 Gregory Zeltser Implantable bioartificial perfusion system
US20140221982A1 (en) 2012-08-29 2014-08-07 Erik Gatenholm Semipermeable medical pouches and their uses
US9526880B2 (en) 2013-03-07 2016-12-27 Viacyte, Inc. 3-dimensional large capacity cell encapsulation device assembly
WO2014173441A1 (en) 2013-04-24 2014-10-30 Nestec S.A. Encapsulation device
EP2815773B1 (en) 2013-06-17 2017-08-30 Hans U. Baer Matrix and implant for tissue engineering
CA2922483A1 (en) 2013-09-11 2015-03-19 Neurotech Usa, Inc. Encapsulated cell therapy cartridge
US10231817B2 (en) 2013-09-24 2019-03-19 Giner Life Sciences, Inc. System for gas treatment of a cell implant
FR3014316B1 (fr) 2013-12-10 2017-01-20 Defymed Organe bioartificiel
US10092507B2 (en) 2014-06-06 2018-10-09 Nanovault Medical Llc Implantable cellular and biotherapeutic agent delivery canister
US10434122B2 (en) 2014-09-24 2019-10-08 The Governors Of The University Of Alberta Cellular transplant site
CA2995578A1 (en) 2015-08-14 2017-02-23 The General Hospital Corporation Systems for and methods for using biomimetic structures providing communication in living tissue
AU2016308652B2 (en) 2015-08-17 2021-06-03 The Johns Hopkins University Fiber-hydrogel composite surgical meshes for tissue repair
WO2017053751A1 (en) 2015-09-24 2017-03-30 California Institute Of Technology Implantable device for retaining live cells and providing nutrients thereto
WO2017062757A1 (en) 2015-10-08 2017-04-13 Massachusetts Institute Of Technology In situ expansion of engineered devices for regeneration
US20170105832A1 (en) 2015-10-15 2017-04-20 Kenneth Samuel Rosenblum Porous membrane structures and related techniques
KR20190031195A (ko) 2015-11-12 2019-03-25 바이오스테이지, 인크. 위장 조직을 생성하기 위한 시스템 및 방법
CA3025344A1 (en) 2016-05-25 2017-11-30 Salk Institute For Biological Studies Compositions and methods for organoid generation and disease modeling
US20190119462A1 (en) 2016-06-14 2019-04-25 The Regents Of The University Of California Porous Polymer Scaffolds, and Methods of Making and Using the Same
US20190282623A1 (en) 2016-09-21 2019-09-19 Cellheal As Implantable Device and 3D Bioprinting Methods for Preparing Implantable Device to Deliver Islets of Langerhans
WO2018071967A1 (en) 2016-10-20 2018-04-26 Australian Foundation for Diabetes Research Cell associated scaffolds for delivery of agents
US10597639B2 (en) 2016-10-20 2020-03-24 Washington University 3D-printed scaffold device for cell transplantation
US11338068B2 (en) 2016-11-08 2022-05-24 W. L. Gore & Associates, Inc. Two-part implantable therapy delivery device
US10849731B2 (en) 2016-11-08 2020-12-01 W. L. Gore & Associates, Inc. Cell encapsulation devices containing structural spacers

Also Published As

Publication number Publication date
JP2013503014A (ja) 2013-01-31
PL3290061T3 (pl) 2020-11-02
HK1247860A1 (zh) 2018-10-05
KR20170117215A (ko) 2017-10-20
US9011899B2 (en) 2015-04-21
CN102596273A (zh) 2012-07-18
WO2011025977A2 (en) 2011-03-03
US20150209479A1 (en) 2015-07-30
JP5976883B2 (ja) 2016-08-24
ES2806645T3 (es) 2021-02-18
JP7416847B2 (ja) 2024-01-17
SI2470228T1 (en) 2018-02-28
SG10201405256VA (en) 2014-10-30
EP2470228A2 (en) 2012-07-04
PT2470228T (pt) 2018-01-12
HUE051328T2 (hu) 2021-03-01
JP2020089790A (ja) 2020-06-11
MX2012002440A (es) 2012-06-19
SI3290061T1 (sl) 2020-09-30
KR102057016B1 (ko) 2019-12-17
JP6676719B2 (ja) 2020-04-08
JP5756108B2 (ja) 2015-07-29
IL218360A0 (en) 2012-04-30
KR20190141017A (ko) 2019-12-20
EA201992021A1 (ru) 2020-08-31
EP2470228B1 (en) 2017-10-04
US20230347018A1 (en) 2023-11-02
JP2015157146A (ja) 2015-09-03
US10034963B2 (en) 2018-07-31
NZ615383A (en) 2014-03-28
PL2470228T3 (pl) 2018-03-30
BR112012004385B1 (pt) 2021-09-14
JP2022082612A (ja) 2022-06-02
EA201690437A1 (ru) 2016-10-31
US20190240375A1 (en) 2019-08-08
KR101919728B1 (ko) 2018-11-16
NZ598701A (en) 2014-03-28
KR20190095516A (ko) 2019-08-14
US20160151541A1 (en) 2016-06-02
WO2011025977A3 (en) 2011-06-16
ES2653241T3 (es) 2018-02-06
SG10202001012VA (en) 2020-04-29
NO2470228T3 (ru) 2018-03-03
JP2018043013A (ja) 2018-03-22
CN102596273B (zh) 2014-11-05
US11730860B2 (en) 2023-08-22
CY1123841T1 (el) 2022-03-24
KR20180124156A (ko) 2018-11-20
EA033785B1 (ru) 2019-11-25
EP3290061B1 (en) 2020-06-10
KR102194187B1 (ko) 2020-12-22
PT3290061T (pt) 2020-07-20
IL218360A (en) 2014-07-31
SG178565A1 (en) 2012-04-27
MX353390B (es) 2018-01-10
EP3290061A1 (en) 2018-03-07
KR102008762B1 (ko) 2019-08-09
DK3290061T3 (da) 2020-07-13
BR112012004385A2 (pt) 2021-01-26
AU2010286531B2 (en) 2014-02-06
HUE036464T2 (hu) 2018-07-30
AU2010286531A1 (en) 2012-04-05
US10207026B2 (en) 2019-02-19
KR101785743B1 (ko) 2017-10-16
EA025142B1 (ru) 2016-11-30
CA2772375A1 (en) 2011-03-03
EA201270337A1 (ru) 2012-10-30
HRP20200982T1 (hr) 2020-11-27
JP2016163768A (ja) 2016-09-08
JP2019005626A (ja) 2019-01-17
KR20120091008A (ko) 2012-08-17
CA2772375C (en) 2020-06-30
US20120245705A1 (en) 2012-09-27
HRP20171926T1 (hr) 2018-02-23
JP6446111B2 (ja) 2018-12-26
CY1119719T1 (el) 2018-06-27
LT3290061T (lt) 2020-07-27
LT2470228T (lt) 2018-02-12
DK2470228T3 (en) 2018-01-02

Similar Documents

Publication Publication Date Title
IN2012DN02668A (ru)
MX2009004238A (es) Metodos y composiciones para tratamiento de defectos oseos con poblaciones de celulas de placenta.
MX353245B (es) Metodos para reprogramar células y sus usos.
HK1144078A1 (en) Method for preparing porous scaffold for tissue engineering
WO2009158480A3 (en) Stimulation of cartilage formation using reduced pressure treatment and chondrocytes
MX2012007414A (es) Diferenciacion de celulas madres embrionarias humanas.
WO2010108126A3 (en) Reprogramming compositions and methods of using the same
GB2485112A (en) Differentiation of human embryonic stem cells
MX2010001335A (es) Diferenciacion de celulas madre embrionarias humanas.
MX356756B (es) Células madre pluripotentes en microportadores.
WO2011109834A3 (en) Enhancement of skeletal muscle stem cell engrafment by dual delivery of vegf and igf-1
MX2021010536A (es) Uso de microparticulas y celulas endoteliales con organos y tejidos descelularizados.
AU2010314984A8 (en) Germline stem cell banking system
MX2015012729A (es) Celulas discogenicas aisladas, metodos de uso y metodos de preparacion de las mismas a partir de tejido de mamiferos.
SG11201804755VA (en) Method for manufacturing tissue/organ by using blood cells
EP4074819A4 (en) METHOD FOR PRODUCING MESENCHYMAL STEM CELLS FROM HUMAN PLURIPOTENT STEM CELLS AND MESENCHYMAL STEM CELLS PRODUCED THEREFROM
WO2008062010A3 (en) Method for making activated carboxypeptidases
WO2014100816A3 (en) Ghrh agonists for islet cell transplantation and function and the treatment of diabetes
WO2011112976A3 (en) Methods for regenerating skeletal muscle
WO2014197798A3 (en) Transplantation device and method of use
MX364349B (es) Lumbrera cónica.
WO2012080825A3 (en) Vertical bone augmentation using endothelial progenitor cells
UA39646U (ru) Способ введения культуры стволовых клеток в зону поврежденного миокарда
WO2010013231A3 (en) Coagulation factor modulation for controlling transplant organ size
UA43180U (ru) Способ консервативного и хирургического лечения гиперплазии вилочковой железы у детей